1. Adenovirus-vectored Ebola vaccines. (3rd October 2015) Authors: Gilbert, Sarah C Journal: Expert review of vaccines Issue: Volume 14:Number 10(2015) Page Start: 1347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus. (5th October 2022) Authors: Fidler, Sarah; Fox, Julie; Tipoe, Timothy; Longet, Stephanie; Tipton, Tom; Abeywickrema, Movin; Adele, Sandra; Alagaratnam, Jasmini; Ali, Mohammad; Aley, Parvinder K; Aslam, Suhail; Balasubramanian, Anbhu; Bara, Anna; Bawa, Tanveer; Brown, Anthony; Brown, Helen; Cappuccini, Federica; Davies, Soph... Journal: Clinical infectious diseases Issue: Volume 76:Number 2(2023) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial. Issue 3 (March 2023) Authors: Madhi, Shabir A; Kwatra, Gaurav; Richardson, Simone I; Koen, Anthonet L; Baillie, Vicky; Cutland, Clare L; Fairlie, Lee; Padayachee, Sherman D; Dheda, Keertan; Barnabas, Shaun L; Bhorat, Qasim Ebrahim; Briner, Carmen; Ahmed, Khatija; Aley, Parvinder K; Bhikha, Sutika; Bhorat, A E; Esmail, Aliasga... Journal: Lancet infectious diseases Issue: Volume 23:Issue 3(2023) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Issue 10282 (10th April 2021) Authors: Emary, Katherine R W; Golubchik, Tanya; Aley, Parvinder K; Ariani, Cristina V; Angus, Brian; Bibi, Sagida; Blane, Beth; Bonsall, David; Cicconi, Paola; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Cox, Tony; Darton, Thomas C; Dold, Christina; Douglas, Alexander D; Duncan, Christoph... Journal: Lancet Issue: Volume 397:Issue 10282(2021) Page Start: 1351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases. Issue 3 (March 2015) Authors: Tully, Claire M; Lambe, Teresa; Gilbert, Sarah C; Hill, Adrian V S Journal: Lancet infectious diseases Issue: Volume 15:Issue 3(2015:Mar.) Page Start: 356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases. Issue 3 (March 2015) Authors: Tully, Claire M; Lambe, Teresa; Gilbert, Sarah C; Hill, Adrian V S Journal: Lancet infectious diseases Issue: Volume 15:Issue 3(2015:Mar.) Page Start: 356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Influenza vaccines and immunopathology. (August 2012) Authors: Gilbert, Sarah C Journal: Expert review of vaccines Issue: Volume 11:Number 8(2012) Page Start: 873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modified Vaccinia Ankara–Vectored Vaccine Expressing Nucleoprotein and Matrix Protein 1 (M1) Activates Mucosal M1-Specific T-Cell Immunity and Tissue-Resident Memory T Cells in Human Nasopharynx-Associated Lymphoid Tissue. (19th November 2019) Authors: Puksuriwong, Suttida; Ahmed, Muhammad S; Sharma, Ravi; Krishnan, Madhan; Leong, Sam; Lambe, Teresa; McNamara, Paul S; Gilbert, Sarah C; Zhang, Qibo Journal: Journal of infectious diseases Issue: Volume 222:Number 5(2020) Page Start: 807 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery. (December 2014) Authors: Pavot, Vincent; Berthet, Morgane; Rességuier, Julien; Legaz, Sophie; Handké, Nadège; Gilbert, Sarah C; Paul, Stéphane; Verrier, Bernard Journal: Nanomedicine Issue: Volume 9:Number 17(2014) Page Start: 2703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Issue 10304 (11th September 2021) Authors: Flaxman, Amy; Marchevsky, Natalie G; Jenkin, Daniel; Aboagye, Jeremy; Aley, Parvinder K; Angus, Brian; Belij-Rammerstorfer, Sandra; Bibi, Sagida; Bittaye, Mustapha; Cappuccini, Federica; Cicconi, Paola; Clutterbuck, Elizabeth A; Davies, Sophie; Dejnirattisai, Wanwisa; Dold, Christina; Ewer, Katie... Journal: Lancet Issue: Volume 398:Issue 10304(2021) Page Start: 981 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗